3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
6
Urinary Bladder Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Anus Neoplasms
2
Tongue Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
PRETEXT I Hepatoblastoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Klatskin Tumor
1
Hypopharyngeal Neoplasms
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Interventions
Cyclophosphamide
28
Rituximab
23
fludarabine
14
fludarabine phosphate
12
Specimen Handling
11
obinutuzumab
10
ibrutinib
10
Magnetic Resonance Spectroscopy
10
Prednisone
8
Doxorubicin
8
tocilizumab
7
polatuzumab vedotin
7
X-Rays
7
Whole-Body Irradiation
7
Phantoms, Imaging
7
Mycophenolic Acid
7
Etoposide
7
Biopsy
7
venetoclax
6
glofitamab
6
Melphalan
6
Lenalidomide
6
Bendamustine Hydrochloride
6
pirtobrutinib
5
acalabrutinib
5
Vincristine
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Gemcitabine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
dehydroftorafur
×
90 days
×
Clear all
No trials found.